Dual Diagnosis: What NICE NG58 Requires for Co-Occurring Mental Illness and Substance Misuse

People with coexisting severe mental illness and substance misuse — often referred to as dual diagnosis — have historically fallen through gaps between mental health and substance misuse services, each sometimes treating the other condition as a reason to defer care. NICE guideline NG58 sets out a specific, named framework designed to close that gap, and it's a core compliance reference for any mental health or substance misuse service working with this population.

The "no wrong door" principle

NG58's central organising principle is that services should identify and provide support to people with coexisting severe mental illness and substance misuse wherever they present — not only within a specialist dual diagnosis service, but across health, social care, housing, criminal justice and voluntary sector settings. The guideline is explicit that the aim is to meet someone's immediate needs at the point of contact, rather than directing them elsewhere first. For frontline staff in any of these settings, this means a presentation that looks primarily like a substance misuse issue, or primarily like a mental health crisis, shouldn't be used as a reason to defer engagement until the "right" service is involved.

Mental health services take the lead — but it's not a diagnosis-based handoff

NG58 specifies that mental health services take the lead role for assessment and care planning for this population, with a designated care coordinator in community mental health services acting as the person's primary point of contact. This is a deliberate design choice: rather than leaving coordination ambiguous between two services, NG58 assigns clear lead responsibility, which gives compliance auditors a specific, checkable question — does this person have a named, documented care coordinator in mental health services, not just substance misuse support running in parallel.

Joint working isn't optional good practice — it's specified

NG58 sets out concrete joint working requirements rather than leaving multi-agency collaboration to local discretion: shared responsibilities and regular communication between services, multi-agency case review meetings held at minimum annually, consistent referral processes and care pathways between mental health and substance misuse services, agreed information-sharing protocols, and cross-sector coordination that addresses physical health, housing and social care needs alongside substance misuse itself. A service that can evidence individual casework but has no documented multi-agency review process has a genuine gap against this standard.

The non-exclusion principle: missed appointments aren't a discharge trigger

One of NG58's most practically significant recommendations addresses a historically common failure point directly: a person must not be automatically discharged from their care plan because they missed an appointment. Instead, non-attendance should be discussed collaboratively across the team involved, and loss of contact should trigger immediate follow-up action rather than case closure. This is a meaningful shift from standard outpatient discharge policy in many services, and it's worth making explicit in staff training — "did not attend" protocols that apply generically across a service may not be compliant with NG58 when applied to someone with a dual diagnosis care plan.

What this means for staff training and service design

For services reviewing compliance against NG58, three checks are particularly worth prioritising: whether care coordinator roles are explicitly assigned and documented for every dual diagnosis case, not assumed informally; whether multi-agency case review meetings are actually happening at least annually and are minuted; and whether the service's standard non-attendance or discharge policy has been specifically reviewed to confirm it doesn't default to discharge for this population. Staff training should cover the "no wrong door" principle explicitly — frontline workers in housing, criminal justice and voluntary sector settings often aren't aware they have a role under this guidance, not just specialist mental health or substance misuse staff.

Frequently asked questions

Does NG58 apply to all substance misuse and mental health presentations, or just severe cases?
NG58 is specifically scoped to coexisting severe mental illness and substance misuse — conditions like psychosis, bipolar disorder or severe depression alongside substance dependency — rather than milder or more transient presentations of either.

Who is responsible for assessment if someone presents to a substance misuse service first?
Under NG58's "no wrong door" principle, the substance misuse service should still identify and respond to immediate needs rather than requiring the person to be referred elsewhere first, but overall care planning leadership sits with mental health services once engaged.

Is there a newer NICE quality standard specifically for this area?
NICE has also published quality standard QS188 alongside NG58, translating the guideline's recommendations into specific, measurable statements that services and commissioners can audit against directly.

Joint working competency for co-occurring conditions is a distinct, specified CPD area for mental health and substance misuse staff. Explore Learnsignal's CPD courses to keep this training current.

Medication oversight for a group that's often excluded from existing safeguards

People with a dual diagnosis are frequently prescribed multiple psychotropic medications to manage both the mental illness and the substance misuse presentation, yet the national programmes built to catch inappropriate psychotropic prescribing — such as STOMP's antipsychotic medication reviews in dementia and learning disability services — weren't originally designed with this population's specific combination of risks in mind. NICE NG58's expectation that mental health and substance misuse treatment be delivered as a single, coordinated care plan rather than two parallel referrals is partly a response to this gap: a medication review that only considers the mental illness, without accounting for interactions with substances the person may still be using, is not the integrated approach the guideline calls for. CPD content for staff in this sector should treat medication oversight as a genuinely joint clinical decision, not a mental health prescribing decision with a substance misuse note attached afterwards.